The intersection of dermatology and allergy is a fascinating space where two disciplines meet to solve some of the most frustrating, chronic conditions patients face. At the 2026 Elevate Derm Rapids Conference, Victoria Garcia-Albea, a dermatology NP, sat down with allergist Dr. Payel Gupta to discuss everything from chronic hives and the traps of food restriction to the "atopic march."
Here are the key clinical insights and patient-first takeaways from their cross-specialty conversation.
One of the biggest misconceptions about Chronic Spontaneous Urticaria (CSU) is that it is triggered by an outside allergen like food or soap. Dr. Gupta emphasizes that CSU is an intrinsic, pathophysiological process driven heavily by mast cells.
The therapeutic options for CSU are moving rapidly. Dr. Gupta highlights that while second-generation antihistamines are the first-line option (and can be stepped up to 4 times daily), advanced therapies are expanding. From biologics like Omalizumab and Dupilumab to emerging options like Remibrutinab, practitioners have more tools than ever.
Clinical Pearl: Give patients a roadmap on day one. Even if you start them on a simple antihistamine, mention that advanced options exist. When patients know there is a Plan B and Plan C, they leave the clinic feeling hopeful rather than defeated by their chronic journey.
When patients experience chronic hives or severe eczema, their first instinct is often to restrict their diet. This is where dermatology and allergy crosstalk becomes vital.
Dr. Gupta warns that extreme food avoidance is a massive problem that leads to:
If a dermatology patient presents with sudden weight loss and hives, a practitioner might immediately worry about systemic malignancies like lymphoma. However, it may simply be that the patient has restricted themselves to a one- or two-food diet out of fear.
"CSU is an intrinsic process. It is a chronic condition happening inside your body, and it is not your external environment or the food you eat that is causing it."
For complex cases, collaborating with an allergist enables controlled oral food challenges to safely determine what patients can tolerate, restoring their quality of life.
The transcript touched on two practical allergy testing scenarios that frequently cross into dermatological care:
High heat alters the structure of food proteins. For example, component testing can examine specific egg proteins, such as ovomucoid. If a patient is ovomucoid-negative, they might tolerate baked egg. Passing a supervised baked-food challenge can actually help children eventually outgrow their allergy.
Dr. Gupta cautions against broad, unsolicited food panel testing due to high false-positive rates, which can trigger unnecessary dietary restrictions. However, aeroallergen testing (dust mites, pet dander, grasses) is highly beneficial when a patient notes a strict one-to-one clinical correlation—such as their eczema flaring the day after visiting a house with cats.
Atopic multimorbidity is incredibly common due to shared Type 2 inflammatory pathways. The classic Atopic March typically follows a predictable sequence in patients:
While atopic dermatitis and asthma can appear early in infancy, environmental allergic rhinitis usually requires at least 2 years of exposure to manifest.
We are moving rapidly toward personalized medicine. Measuring Type 2 biomarkers—such as elevated IgE levels, eosinophil counts, and FeNO (fractional exhaled nitric oxide) breathing tests—allows clinicians to predict which biologic will work best for a specific patient's phenotype. Targeting shared pathways with a single drug drastically improves patient compliance and mental health.
While these conditions are rarely fatal, Dr. Gupta reminds us that allergic disease is far from benign—asthma still claims 11 lives a day in the United States. Furthermore, the psychological toll of CSU and atopic dermatitis on a patient's quality of life is immense.
Dermatologists should consider a referral to their local allergy team when:
To help patients better understand their conditions without the medical jargon, Dr. Gupta co-hosts a patient-centric podcast called The Itch. It serves as an excellent resource for both patients navigating their diagnoses and providers seeking patient-friendly language for the clinic.
By stepping out of specialty silos and embracing shared decision-making, dermatologists and allergists can build a comprehensive safety net for their most complex patients.
Listen to the entire podcast on Apple Podcasts or Spotify